CRYO.ON

What is CRYO.ON?

CRYO•ON is dimethyl sulfoxide (DMSO) with purity higher than 99,9%, certified for use with human tissues and cells intended for transplantation.

The product is sterile, apyrogenic and mycoplasma-free according to the current Pharmacopoeias (EP and USP).

It is packaged in sterile double pouch to meet GMP requirements.

CRYO•ON complies with the safety requirements regarding the allowable limits of EtO (Ethylene Oxide) for permanent contact devices in compliance with the EN ISO 10993-7 standard (Biological evaluation of medical devices – Part 7: Ethylene oxide sterilization residuals).

Intended use

CRYOPRESERVATION OF HUMAN CARDIOVASCULAR TISSUES, BONE, TENDONS, SKIN, AMNIOTIC MEMBRANE, AND CELLS

Characteristics

STERILE
ENDOTOXIN-TESTED
MYCOPLASMA-FREE
ISO 10993-7 COMPLIANT – SAFETY REQUIREMENTS REGARDING THE ALLOWABLE LIMITS OF EtO (Ethylene Oxide)
SHELF-LIFE: 48 MONTHS
CE MARK: 0477

Technical Documents

CE Certificate 335.83 KB 2373 downloads

AL.CHI.MI.A. S.R.L. production quality system is compliant with Annex Il (excluding...

Download

Technical Sheet - CRN 001-00 525.72 KB 227 downloads

CRYO•ON - 10 ml ...

Download

Technical Sheet - CRN 002-00 525.94 KB 148 downloads

CRYO•ON - 100 ml ...

Download

Technical Sheet - CRN 003-00 525.90 KB 110 downloads

CRYO•ON - 50 ml ...

Download

Publications and Presentations

Establishing a procedure for dimethyl sulfoxide removal from cardiovascular allografts: a quantitative study
Year: 2013 Authors: Gatto C.; Dainese L.; Buzzi M.; Terzi A.; Guarino A.; Pagliaro P.P.; Polvani G.; D’Amato Tothova J. Cell and Tissue Banking 14(2): 205-12, 2013 Online version This [...]
Removal of DMSO from cryopreserved human skin
Year: 2010, EATB Authors: Vassanelli A.; Gatto C.; Bosinelli A.; Rizzi S.; Marchiani A.; Ruzza P.; D’Amato Tóthová J.; Aprili G. Abstract: Elimination of DMSO from cryopreserved skin allografts is one of the crucial [...]
Removal of DMSO from cardiovascular allografts
Year: 2010, EATB Authors: Guarino A.; Gatto C.; Dainese L.; Buzzi M.; Pagliaro P.; D’Amato Tóthová J.; Polvani G.L. Abstract: Elimination of DMSO from cryopreserved allografts is one of the crucial steps in tissue processing [...]
Comparison among the medical devices BASE.128, BASE, CRYO.ON and the solutions currently used in two Italian cardiovascular tissue banks
Year: 2010, EATB Authors: Gatto C.; Marchiani A.; Ruzza P.; Beccaro M.; D’Amato Tóthová, J. Abstract: We evaluated the performances of the HTP medical devices in comparison with solutions currently used by the Cardiovascular Tissue [...]
Removal of Me2SO from cryopreserved skin and heart valves
Year: 2010, CRYO Authors: Gatto C.; Marchiani A.; Ruzza P.; Beccaro M.; D’Amato Tóthová J. Abstract: Elimination of Me2SO from cryopreserved allografts is one of the crucial steps in tissue processing phases in order to [...]

Related products

View Cart

Details

GLYO.ON

Packaging: Vial
Items: 1
Volume: 500 ml

GLYO•ON is glycerol with purity higher than 98%, certified for use with human tissues and cells intended for transplantation.

Category: CryopreservationTissue banking

What is CRYO.ON?

Intended use

Characteristics

Technical Documents

CE Certificate 335.83 KB 2373 downloads

Technical Sheet - CRN 001-00 525.72 KB 227 downloads

Technical Sheet - CRN 002-00 525.94 KB 148 downloads

Technical Sheet - CRN 003-00 525.90 KB 110 downloads

Publications and Presentations

Establishing a procedure for dimethyl sulfoxide removal from cardiovascular allografts: a quantitative study

Removal of DMSO from cryopreserved human skin

Removal of DMSO from cardiovascular allografts

Comparison among the medical devices BASE.128, BASE, CRYO.ON and the solutions currently used in two Italian cardiovascular tissue banks

Removal of Me2SO from cryopreserved skin and heart valves

Related products

GLYO.ON

Request info about CRYO.ON

Request info about CRYO.ON

BASE 128

BASE

GLYO.ON

Ophthalmic Surgery

Human Tissue Banking

Search

THE COMPANY

HEADQUARTER